Release Date: 31/07/19 15:28 Summary: DuluxGroup Shareholders Approve Scheme Price Sensitive: Yes Download Document 352.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%